These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11197584)

  • 1. Trovafloxacin-associated leukopenia.
    Mitropoulos FA; Angood PB; Rabinovici R
    Ann Pharmacother; 2001 Jan; 35(1):41-4. PubMed ID: 11197584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
    Williams DJ; Hopkins S
    Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trovan (trovafloxacin/alatrofloxacin) recalled: why? How?].
    Stenver DI; Ersbøll J; Renneberg J
    Ugeskr Laeger; 1999 Jul; 161(30):4311. PubMed ID: 10439701
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
    Cutler NR; Vincent J; Jhee SS; Teng R; Wardle T; Lucas G; Dogolo LC; Sramek JJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1298-300. PubMed ID: 9174187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
    Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trovafloxacin-induced weakness due to a demyelinating polyneuropathy.
    Murray CK; Wortmann GW
    South Med J; 2000 May; 93(5):514-5. PubMed ID: 10832955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trovafloxacin hepatotoxicity.
    Lazarczyk DA; Goldstein NS; Gordon SC
    Dig Dis Sci; 2001 Apr; 46(4):925-6. PubMed ID: 11330435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alatrofloxacin-induced seizures during slow intravenous infusion.
    Melvani S; Speed BR
    Ann Pharmacother; 2000 Sep; 34(9):1017-9. PubMed ID: 10981247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of trovafloxacin in treatment of lower respiratory tract infections.
    Williams D; Hopkins S
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):454-8. PubMed ID: 9758292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe thrombocytopenia associated with alatrofloxacin.
    Gales BJ; Sulak LB
    Ann Pharmacother; 2000 Mar; 34(3):330-4. PubMed ID: 10917380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
    Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE
    J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trovafloxacin-associated exfoliative dermatitis in a homecare patient.
    Triller DM; Miller MT; Briceland LL; Gordon FS
    Ann Pharmacother; 1999 Oct; 33(10):1122. PubMed ID: 10534226
    [No Abstract]   [Full Text] [Related]  

  • 13. Concentrations of trovafloxacin in colonic tissue and peritoneal fluid after intravenous infusion of the prodrug alatrofloxacin in patients undergoing colorectal surgery.
    Melnik G; Schwesinger WH; Dogolo LC; Teng R; Vincent J
    Am J Surg; 1998 Dec; 176(6A Suppl):14S-17S. PubMed ID: 9935251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin.
    Ball P; Wilson R; Mandell L; Brown J; Henkel T;
    J Chemother; 2001 Jun; 13(3):288-98. PubMed ID: 11450888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute eosinophilic hepatitis from trovafloxacin.
    Chen HJ; Bloch KJ; Maclean JA
    N Engl J Med; 2000 Feb; 342(5):359-60. PubMed ID: 10660405
    [No Abstract]   [Full Text] [Related]  

  • 17. Trovafloxacin: a new fluoroquinolone.
    Alghasham AA; Nahata MC
    Ann Pharmacother; 1999 Jan; 33(1):48-60. PubMed ID: 9972385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trovafloxacin-induced acute hepatitis.
    Lucena MI; Andrade RJ; Rodrigo L; Salmerón J; Alvarez A; Lopez-Garrido MJ; Camargo R; Alcantára R
    Clin Infect Dis; 2000 Feb; 30(2):400-1. PubMed ID: 10671353
    [No Abstract]   [Full Text] [Related]  

  • 19. Proper use versus abuse of trovafloxacin.
    Fulghum MP; Grimaldi D; Schoelles-Williams J
    Am J Health Syst Pharm; 2000 Jan; 57(1):76, 78. PubMed ID: 10630563
    [No Abstract]   [Full Text] [Related]  

  • 20. Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction.
    Hsiao CJ; Younis H; Boelsterli UA
    Chem Biol Interact; 2010 Oct; 188(1):204-13. PubMed ID: 20655887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.